| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 70 |
| 1 | PREDNISONE | 65 |
| 2 | FOLIC ACID | 62 |
| 3 | OMEPRAZOLE | 60 |
| 4 | PANTOPRAZOLE | 51 |
| 5 | RITONAVIR | 46 |
| 6 | QUETIAPINE | 42 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 38 |
| 8 | TACROLIMUS | 37 |
| 9 | LANSOPRAZOLE | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN 500 MG, TABLET | 1 | 0.0256 |
| 1 | OXYCODONE AND ASPIRIN | 1 | 0.0196 |
| 2 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 3 | NICARDIPINE HYDROCHLORIDE | 14 | 0.0062 |
| 4 | PROPYLTHIOURACIL | 10 | 0.0048 |
| 5 | PRAZOSIN HYDROCHLORIDE | 6 | 0.0043 |
| 6 | NICARDIPINE | 15 | 0.0034 |
| 7 | FLURANDRENOLIDE | 1 | 0.0030 |
| 8 | PENICILLIN G POTASSIUM | 2 | 0.0027 |
| 9 | METHYLDOPA | 12 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 122 |
| 1 | Proton Pump Inhibitor [EPC] | 95 |
| 2 | Vitamin C [EPC] | 68 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 4 | Vitamin D [EPC] | 64 |
| 5 | Atypical Antipsychotic [EPC] | 63 |
| 6 | Vitamin B12 [EPC] | 63 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 61 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 60 |
| 9 | Protease Inhibitor [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 1 | Protease Inhibitor [EPC] | 60 | 0.0013 |
| 2 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 12 | 0.0012 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 10 | 0.0010 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 60 | 0.0010 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 42 | 0.0009 |
| 7 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | Calcitonin [EPC] | 2 | 0.0006 |